Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-071958·Bain Capital Life Sciences Opportunities IV, L.P.
Schedule 13G ownership disclosure
Olema Pharmaceuticals Inc
Common Stock, $0.0001 par value per share · CUSIP: 68062P106
Event date: 2025-03-31
- Filing-level shares
- 6,843,954
- Percent of class
- 9.99%
- Bain Capital Life Sciences Opportunities IV, L.P.
Shares: 6,843,954 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-071958
- Form type
- SCHEDULE 13G/A
- Filer
- Bain Capital Life Sciences Opportunities IV, L.P.
- CIK
- CIK 2015553
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership